Inventory increased 44.5%
Inventory changed +44.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed +44.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed -773 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed -19.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed +114.0% from the comparable as-filed period.
Operating cash flow changed +105.8% from the comparable as-filed period.
Current liabilities changed +44.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating income changed +335.6% from the comparable as-filed period.
Trade receivables changed +31.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Total assets changed +50.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capital expenditure changed +74.6% from the comparable as-filed period.
Gross profit changed +26.7% from the comparable as-filed period.
Cash & equivalents changed -10.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed +23.8% from the comparable as-filed period.
Current assets changed +16.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital changed -135.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Shares outstanding changed +0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
Stock-based compensation changed +0.8% from the comparable as-filed period.
Free-cash-flow proxy changed +98.8% from the comparable as-filed period. The change ranks at the 50th percentile of 6 prior comparable changes.
Operating cash flow changed +72.9% from the comparable as-filed period. The change ranks at the 50th percentile of 6 prior comparable changes.
Capital expenditure changed +20.3% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Gross profit changed +26.0% from the comparable as-filed period.
Inventory changed +27.3% from the comparable as-filed period.
Operating income changed +6254.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Research & development changed +20.8% from the comparable as-filed period.
Cash & equivalents changed -9.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net income changed +1931.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Stock-based compensation changed -11.1% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.